Table 1 Characteristics of the patients

Age (year)

49 ± 13

57 ± 15

52 ± 12

56 ± 10

54 ± 13

51 ± 12

Males/females

11/9

10/10

9/11

8/12

12/8

11/9

Height (cm)

158 ± 11

168 ± 11

161 ± 14

165 ± 10

159 ± 12

163 ± 13

Weight (kg)

58 ± 9

65 ± 11

65 ± 12

60 ± 9

57 ± 12

63 ± 9

BMI

21.1 ± 1.8

22.4 ± 2.1

24.1 ± 1.9

21.9 ± 1.7

20.6 ± 2.6

23.1 ± 2.3

ASA I/II

5/15

7/13

5/15

4/16

5/15

4/16

OLV duration (min)

65 ± 14

59 ± 15

61 ± 10

55 ± 9

53 ± 12

63 ± 11

Surgery duration (min)

153 ± 16

149 ± 27

134 ± 23

146 ± 32

143 ± 30

140 ± 25

Infused crystalloid (ml)

644 ± 84

613 ± 88

605 ± 55

599 ± 48

586 ± 55

600 ± 68

Urinary output (ml)

172 ± 18

171 ± 23

175 ± 31

178 ± 36

168 ± 29

164 ± 22

Estimated blood loss (ml)

174 ± 27

172 ± 33

175 ± 31

174 ± 34

165 ± 25

159 ± 21

Bradycardia

0

0

3^ab

0^c

3^abd

6^abcde

Atropine

0

0

3^ab

0^c

3^abd

6^abcde

Hypotension

0

0

2 ^ab

0 ^c

2 ^abd

4 ^abcde

Methoxamine

0

0

2 ^ab

0 ^c

2 ^abd

4 ^abcde